Affinity Asset Advisors »

Arya Sciences Acquisition-a shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Arya Sciences Acquisition-a (ARYD) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Arya Sciences Acquisition-a

Tip: Access up to 7 years of quarterly data

All positions including Arya Sciences Acquisition-a held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arya Sciences Acquisition-a by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.5M 134k 11.27
2021-12-31 $4.0M 400k 9.93
2021-09-30 $6.0M 600k 10.06
2021-06-30 $7.5M 700k 10.72
2021-03-31 $7.3M 700k 10.47

More positions owned by Affinity Asset Advisors

Spdr Ser Tr S&p Biotech Put Option (XBI)
Teva Pharmaceutical Inds Sponsored Ads Call Option (TEVA)
Moderna Put Option (MRNA)
Apogee Therapeutics (APGE)
Xenon Pharmaceuticals (XENE)
Madrigal Pharmaceuticals (MDGL)
Crinetics Pharmaceuticals In (CRNX)
Autolus Therapeutics Spon Ads (AUTL)
Celldex Therapeutics Com New (CLDX)
Arcellx Common Stock (ACLX)
Vera Therapeutics Cl A (VERA)
Inozyme Pharma (INZY)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Kura Oncology (KURA)
Spyre Therapeutics Com New (SYRE)

View all positions for Affinity Asset Advisors

Top funds holding Arya Sciences Acquisition-a

Glazer Capital
Berkley W R
Meteora Capital
Cowen And Company
Mizuho Securities USA
Vivaldi Asset Management
Farallon Capital Management
Tenor Capital Management
Hsbc Holdings
Affinity Asset Advisors
Rtw Investments
Shaolin Capital Management
OZ Management
Exos TFP Holdings
Periscope Capital

View all funds holding Arya Sciences Acquisition-a